Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-2025-04-21

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Reltecimod

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod
    Atox Bio Announces FDA Acceptance to File the NDA for Reltecimod

    10 Dec 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/il/news-releases/atox-bio-announces-fda-acceptance-to-file-the-nda-for-reltecimod-to-treat-suspected-organ-dysfunction-or-failure-in-patients-with-necrotizing-soft-tissue-infection-flesh-eating-disease--843987702.html

    PRNEWSWIRE
    10 Dec 2020
    Share Share